Investments
16Portfolio Exits
1About EMV Capital
EMV Capital is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities and transportation sectors and healthcare.On August 24th, 2020, EMV Capital was acquired by NetScientific. Terms of the transaction were not disclosed.
EMV Capital Headquarter Location
Level 39, One Canada Square
London, England, E14 5AB,
United Kingdom
Latest EMV Capital News
May 6, 2022
The board sees "substantial upside potential" through a multi-pronged growth strategy Vortex specialises in the capture and analysis of circulating tumour cells found in the bloodstream of cancer sufferers NetScientific PLC (AIM:NSCI) said it is acquiring a 30% stake in former investee company Vortex Biotech in a non-cash transaction. It has conditionally agreed to buy the stake in Vortex Biotech Holdings, an Anglo-American technology group that specialises in circulating tumour cell capture and analysis, which provides doctors and scientists with insights into the prevalence and development of cancers as well as guiding potential treatments. Under previous management, NetScientific completed a forced sale of a 95% holding in the business in 2019. Since being spun out of the University of California, Los Angeles (UCLA), Vortex has benefited from US$$38.5mln of historic investment and NetScientific believes the business has been "materially de-risked" in the period since previous management exited. It has made "significant commercial and operational progress, underpinning significant growth prospects", investors were told. With Vortex active in the fast-growing oncology research and liquid biopsy markets, similar to AIM-listed ANGLE, the NetScientific board sees "substantial upside potential" through a growth strategy focused on product and cartridge sales, launching a services lab business, and exploring liquid biopsy opportunities. “The board is accordingly delighted for the group to be in a position to re-acquire an interest in Vortex,” NetScientific added. The consideration for the acquisition is to be satisfied by the transfer of £300,000 of invoices to extinguish obligations and fees payable by Vortex US to EMV Capital for previous services and certain loans made to Vortex by Deeptech. Deeptech was managed by EMV Capital, which has since been bought by NetScientific.
EMV Capital Investments
16 Investments
EMV Capital has made 16 investments. Their latest investment was in Bureau as part of their Series A on December 12, 2021.
EMV Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/16/2021 | Series A | Bureau | $12M | Yes | 15 | |
12/13/2021 | Unattributed VC - II | Martlet Capital | No | 1 | ||
11/16/2021 | Seed VC - II | Clinikk | $4M | Yes | 10 | |
9/16/2021 | Unattributed VC | |||||
6/22/2021 | Seed VC - II |
Date | 12/16/2021 | 12/13/2021 | 11/16/2021 | 9/16/2021 | 6/22/2021 |
---|---|---|---|---|---|
Round | Series A | Unattributed VC - II | Seed VC - II | Unattributed VC | Seed VC - II |
Company | Bureau | Martlet Capital | Clinikk | ||
Amount | $12M | $4M | |||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 15 | 1 | 10 |
EMV Capital Portfolio Exits
1 Portfolio Exit
EMV Capital has 1 portfolio exit. Their latest portfolio exit was Credenc on August 20, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
8/20/2021 | Acquired | 2 |
Date | 8/20/2021 |
---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 2 |
EMV Capital Acquisitions
2 Acquisitions
EMV Capital acquired 2 companies. Their latest acquisition was Vortex Biosciences on April 26, 2019.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
4/26/2019 | Other | $0.37M | Acq - Fin | 2 | ||
4/17/2019 |
Date | 4/26/2019 | 4/17/2019 |
---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | $0.37M | |
Note | Acq - Fin | |
Sources | 2 |
EMV Capital Team
2 Team Members
EMV Capital has 2 team members, including current Managing Director, Ilian Iliev.
Name | Work History | Title | Status |
---|---|---|---|
Ilian Iliev | EcoMachines Incubator | Managing Director | Current |
Dr. Iliev | Managing Director | Current |
Name | Ilian Iliev | Dr. Iliev |
---|---|---|
Work History | EcoMachines Incubator | |
Title | Managing Director | Managing Director |
Status | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.